Inspire Medical director awarded 346 shares

Tansey Casey M reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Tansey Casey M reported acquisition or exercise transactions in this Form 4 filing.

Inspire Medical Systems, Inc. director Casey M. Tansey reported a grant of 346 shares of common stock on July 15, 2026. The shares were received at 0.0000 per share in lieu of cash fees under the company’s Non-Employee Director Compensation Policy. After this award, Tansey directly holds 26,632 shares and also reports indirect ownership of 500 shares held by The Kimberly Tansey Irrevocable Trust and 500 shares held by The Kylie Tansey Irrevocable Trust.

Insider Trade Summary

Grant/Award: 346 shares

Grant/Award 3 txns

Insider Tansey Casey M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	346	$0.00	$0.00
holding	Common Stock F2	--	--	--
holding	Common Stock F3	--	--	--

Holdings After Transaction: Common Stock — 26,632 shares (Direct); Common Stock — 1,000 shares (Indirect, By Family Trust)

Footnotes (3)

1. F1. Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.
2. F2. Securities held by The Kimberly Tansey Irrevocable Trust.
3. F3. Securities held by The Kylie Tansey Irrevocable Trust.

Key Figures

Share grant: 346 shares Grant price: 0.0000 per share Direct holdings after grant: 26,632 shares +2 more

5 metrics

Share grant 346 shares Common stock granted on July 15, 2026 under director compensation policy

Grant price 0.0000 per share Reported price per share for the 346-share award

Direct holdings after grant 26,632 shares Common shares directly held by Casey M. Tansey after the reported transaction

Kimberly Tansey Trust holdings 500 shares Common shares held indirectly via The Kimberly Tansey Irrevocable Trust

Kylie Tansey Trust holdings 500 shares Common shares held indirectly via The Kylie Tansey Irrevocable Trust

Key Terms

Non-Employee Director Compensation Policy, Irrevocable Trust, in lieu of cash fees

3 terms

Non-Employee Director Compensation Policy financial

"in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy."

Irrevocable Trust financial

"Securities held by The Kimberly Tansey Irrevocable Trust."

An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.

in lieu of cash fees financial

"Represents shares of common stock received in lieu of cash fees pursuant to the Company's policy."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Casey M. Tansey report in Inspire Medical Systems (INSP) Form 4?

Casey M. Tansey reported a grant of 346 shares of Inspire Medical Systems common stock on July 15, 2026. The shares were received at 0.0000 per share in lieu of cash fees under the company’s Non-Employee Director Compensation Policy.

How many Inspire Medical Systems (INSP) shares does Casey M. Tansey now hold directly?

Following the reported grant, Casey M. Tansey directly holds 26,632 shares of Inspire Medical Systems common stock. This figure reflects Tansey’s direct ownership position as disclosed in the Form 4 filing for the July 15, 2026 transaction.

What is the nature of the 346-share transaction reported for INSP?

The 346-share transaction is a grant or award, coded "A", representing shares received in lieu of cash director fees. It was made under Inspire Medical Systems’ Non-Employee Director Compensation Policy rather than through an open-market purchase.

What indirect holdings did Casey M. Tansey disclose in INSP’s Form 4?

Casey M. Tansey reported 500 shares of Inspire Medical Systems common stock held by The Kimberly Tansey Irrevocable Trust and 500 shares held by The Kylie Tansey Irrevocable Trust, both reported as indirect ownership positions.

Was the reported INSP Form 4 transaction made under a Rule 10b5-1 trading plan?

The Form 4 indicates the Rule 10b5-1 checkbox is not marked, so the reported grant and holdings were not designated as being effected pursuant to a Rule 10b5-1 trading plan in this filing.

What price per share was reported for the 346 Inspire Medical Systems shares granted to Tansey?

The 346-share award to Casey M. Tansey was reported at 0.0000 per share. This reflects that the shares were granted in lieu of cash director fees, rather than purchased for cash in the market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/17/2026 - 09:27 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tansey Casey M

(Last) (First) (Middle)

C/O INSPIRE MEDICAL SYSTEMS, INC.

5500 WAYZATA BLVD., SUITE 1600

(Street)

GOLDEN VALLEY MINNESOTA 55416

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Inspire Medical Systems, Inc. [ INSP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/15/2026		A		346(1)	A	$0	26,632	D
Common Stock								500	I	By Family Trust(2)
Common Stock								500	I	By Family Trust(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy.

2. Securities held by The Kimberly Tansey Irrevocable Trust.

3. Securities held by The Kylie Tansey Irrevocable Trust.

Remarks:

Exhibit 24 - Power of Attorney.

	/s/ Bryan Phillips, Attorney-in-Fact for Casey M. Tansey	07/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)